Options for members in excluded plans: Pursue the OSA indication if applicable Advocate with HR for benefit expansion Use LillyDirect or out-of-pocket options Consider compounded tirzepatide as a separate category (different regulatory status, different product) Some employers have added obesity drug coverage in 2024-2025 in response to employee advocacy and broader cultural shifts
Decreases appetite and reduces cravings Promotes weight loss 2-4 Lowers A1C levels (a marker of blood sugar control) Improves cardiometabolic health measures Enhances insulin sensitivity 1-3 The medication is not insulin
In addition, multidisciplinary approaches often produce the best outcomes
Ameen Masoodi, a Family Medicine Physician, explains: "Injection site reactions are common, but they are usually mild and diminish as you become used to the medication." Heres what you might notice: redness or pink skin that feels warm to the touch, mild swelling forming a small raised bump, a brief sting or dull ache during or right after the injection, itching , small bruises from hitting tiny blood vessels, or firm lumps that can last up to a week
Published online April 23, 2013
Self-administering research-grade peptides purchased online, however, carries serious risks due to the lack of regulatory oversight